Sunday, 8 October 2017

PSILOCIN OR 4-HO-DMT SOLUTION


1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material
·        
 MDL number MFCD00079228

·          PubChem Substance ID 329820066

Properties

Related Categories
grade  
certified reference material
InChI Key  
SPCIYGNTAMCTRO-UHFFFAOYSA-N
feature  
(Snap-N-Spike®)
packaging  
ampule of 1 mL
drug control  
Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIA (Portugal)
concentration  
1.0 mg/mL in acetonitrile
storage temp.  
−70°C
·          
Psilocin (also known as 4-HO-DMT, psilocine, psilocyn, or psilotsin) is a substituted tryptamine alkaloid and a serotonergic psychedelic substance. It is present in most psychedelic mushrooms together with its phosphorylated counterpart psilocybin.
Detailed Description:
is a Schedule I drug under the Convention on Psychotropic Substances.[2] The mind-altering effects of psilocin are highly variable and subjective and resemble those of LSD and DMT.

Chemistry

Psilocin and its phosphorylated cousin, psilocybin, were first isolated and named in 1958 by Swiss chemist Albert Hofmann. Hofmann obtained the chemicals from laboratory-grown specimens of the entheogenic mushroom Psilocybe mexicana. Hofmann also succeeded in finding the synthetic routes to these chemicals.[3]
Psilocin can be obtained by dephosphorylation of natural psilocybin under strongly acidic or under alkaline conditions (hydrolysis). Another synthetic route uses the Speeter-Anthony tryptamine synthesis starting from 4-hydroxyindole.
Psilocin is relatively unstable in solution due to its phenolic hydroxy (-OH) group. In the presence of oxygen it readily forms bluish and dark black degradation products. Similar products are also formed under acidic conditions in the presence of oxygen and Fe3+ ions (Keller's reagent).

Structural analogs

Sulfur analogs are known with a benzothienyl replacement[4] as well as 4-SH-DMT.[5] 1-Methylpsilocin is a functionally 5-HT2Creceptor preferring agonist.[6] 4-Fluoro-N,N-dimethyltryptamine is known.[6] O-Acetylpsilocin (4-AcO-DMT) is an acetylated analog of psilocin. Additionally, replacement of a methyl group at the dimethylated nitrogen with an isopropyl or ethyl group yields 4-HO-MIPT (4-hydroxy-N-methyl-N-isopropyltryptamine) and 4-HO-MET (4-hydroxy-N-methyl-N-ethyltryptamine), respectively.

Pharmacology

Psilocin is the pharmacologically active agent in the body after ingestion of psilocybin or some species of psychedelic mushrooms.
Psilocybin is rapidly dephosphorylated in the body to psilocin which acts as a 5-HT2A, 5-HT2C and 5-HT1A agonist or partial agonist. Psilocin exhibits functional selectivity in that it activates phospholipase A2 instead of activating phospholipase C as the endogenous ligand serotonin does. Psilocin is structurally similar to serotonin (5-HT),[7] differing only by the hydroxyl group being on the 4-position rather than the 5 and the dimethyl groups on the nitrogen. Its effects are thought to come from its partial agonist activity at 5-HT2Aserotonin receptors in the prefrontal cortex.
Psilocin has no significant effect on dopamine receptors (unlike LSD) and only affects the noradrenergic system at very high dosages.[8]
Psilocin's half-life ranges from 1 to 3 hours.[1]
See psilocybin for more details

Behavioral and non-behavioral effects

Its physiological effects are similar to a sympathetic arousal state. Specific effects observed after ingestion can include but are not limited to tachycardia, dilated pupils, restlessness or arousal, euphoria, open and closed eye visuals (common at medium to high doses), synesthesia (e.g. hearing colours and seeing sounds), increased body temperature, headache, sweating and chills, and nausea. Psilocybin is rapidly dephosphorylated in the body to psilocin which acts as a 5-HT2A, 5-HT2C and 5-HT1A agonist or partial agonist. Receptors are claimed to significantly regulate visuals, decision making, mood, decreased blood pressure and heart rate.[7]
There is virtually no direct lethality associated with psilocin.[7] There is virtually no withdrawal syndrome when chronic use of this drug is ceased.[7] There is cross tolerance among psilocin, mescaline, LSD,[7] and other 5-HT2A, 5-HT2C, and 5-HT1A agonists due to down-regulation of these receptors.

PRICES

$125584.65/KG OR $57083.93/IB

For more information:

mobile: +2348039721941

contact person: emeaba uche

e-mail: emeabau@yahoo.com





No comments:

Post a Comment